Axsome Therapeutics AXSM Earnings Call Transcripts

NASDAQ AXSM
$140.97 +7.01 (+5.23%)
At close: Nov 10, 2026 · 4:00 PM EST
27 earnings calls on file for Axsome Therapeutics, from Q4 2019 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Axsome Therapeutics Q3 2026 Earnings Call

Nov 2, 2026 7,268 words · 32 min read
  • Ashley DongSenior Director of Investor Relations
  • Herriot TabuteauChief Executive Officer
  • Nick PizzieChief Financial Officer
  • Ari MaizelChief Commercial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Axsome Therapeutics Earnings Call Transcripts

Calls27
LatestNov 2, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2024

Fiscal 2023

Fiscal 2022

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 27 Axsome Therapeutics transcripts Register to get access to Axsome Therapeutics’s earnings call transcripts.